Annual Working Capital
$43.02 M
-$24.54 M-36.33%
30 April 2024
Summary:
PharmaCyte Biotech annual working capital is currently $43.02 million, with the most recent change of -$24.54 million (-36.33%) on 30 April 2024. During the last 3 years, it has risen by +$41.47 million (+2674.67%). PMCB annual working capital is now -49.26% below its all-time high of $84.79 million, reached on 30 April 2022.PMCB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$25.40 M
-$17.62 M-40.95%
31 July 2024
Summary:
PharmaCyte Biotech quarterly working capital is currently $25.40 million, with the most recent change of -$17.62 million (-40.95%) on 31 July 2024. Over the past year, it has dropped by -$43.11 million (-62.92%). PMCB quarterly working capital is now -70.80% below its all-time high of $86.99 million, reached on 31 October 2021.PMCB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.3% | -62.9% |
| 3 y3 years | +2674.7% | -70.8% |
| 5 y5 years | +10000.0% | +4372.2% |
PMCB Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -49.3% | +2674.7% | -70.8% | at low |
| 5 y | 5 years | -49.3% | >+9999.0% | -70.8% | +3237.3% |
| alltime | all time | -49.3% | +1409.7% | -70.8% | +852.5% |
PharmaCyte Biotech Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $25.40 M(-41.0%) |
| Apr 2024 | $43.02 M(-36.3%) | $43.02 M(-20.3%) |
| Jan 2024 | - | $53.97 M(-21.2%) |
| Oct 2023 | - | $68.51 M(-6.5%) |
| July 2023 | - | $73.23 M(+8.4%) |
| Apr 2023 | $67.56 M(-20.3%) | $67.56 M(-6.2%) |
| Jan 2023 | - | $71.99 M(-5.2%) |
| Oct 2022 | - | $75.91 M(-6.5%) |
| July 2022 | - | $81.17 M(-4.3%) |
| Apr 2022 | $84.79 M(+5368.9%) | $84.79 M(-1.6%) |
| Jan 2022 | - | $86.20 M(-0.9%) |
| Oct 2021 | - | $86.99 M(>+9900.0%) |
| July 2021 | - | $583.40 K(-62.4%) |
| Apr 2021 | $1.55 M(>+9900.0%) | $1.55 M(-37.8%) |
| Jan 2021 | - | $2.49 M(-21.3%) |
| Oct 2020 | - | $3.17 M(+175.5%) |
| July 2020 | - | $1.15 M(>+9900.0%) |
| Apr 2020 | $6200.00(-106.9%) | $6200.00(-100.8%) |
| Jan 2020 | - | -$809.70 K(+36.2%) |
| Oct 2019 | - | -$594.60 K(+358.8%) |
| July 2019 | - | -$129.60 K(+44.8%) |
| Apr 2019 | -$89.50 K(-114.0%) | -$89.50 K(-137.8%) |
| Jan 2019 | - | $236.70 K(-14.0%) |
| Oct 2018 | - | $275.20 K(-74.3%) |
| July 2018 | - | $1.07 M(+67.1%) |
| Apr 2018 | $639.70 K(-78.4%) | $639.70 K(-9.8%) |
| Jan 2018 | - | $709.00 K(-68.1%) |
| Oct 2017 | - | $2.22 M(-37.1%) |
| July 2017 | - | $3.53 M(+19.3%) |
| Apr 2017 | $2.96 M(+112.3%) | $2.96 M(+55.1%) |
| Jan 2017 | - | $1.91 M(+65.4%) |
| Oct 2016 | - | $1.15 M(-40.5%) |
| July 2016 | - | $1.94 M(+39.1%) |
| Apr 2016 | $1.39 M(-47.4%) | $1.39 M(-22.9%) |
| Jan 2016 | - | $1.81 M(+26.2%) |
| Oct 2015 | - | $1.43 M(-21.6%) |
| July 2015 | - | $1.83 M(-31.0%) |
| Apr 2015 | $2.65 M(-30.6%) | $2.65 M(+328.1%) |
| Jan 2015 | - | $618.50 K(-38.3%) |
| Oct 2014 | - | $1.00 M(-62.8%) |
| July 2014 | - | $2.70 M(-29.2%) |
| Apr 2014 | $3.81 M | $3.81 M(+259.2%) |
| Jan 2014 | - | $1.06 M(-304.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2013 | - | -$518.40 K(-164.0%) |
| July 2013 | - | $810.20 K(-141.5%) |
| Apr 2013 | -$1.95 M(-28.5%) | -$1.95 M(-10.8%) |
| Jan 2013 | - | -$2.19 M(-1.1%) |
| Oct 2012 | - | -$2.21 M(-21.6%) |
| July 2012 | - | -$2.82 M(+3.4%) |
| Apr 2012 | -$2.73 M(-16.9%) | -$2.73 M(+7.8%) |
| Jan 2012 | - | -$2.53 M(-13.1%) |
| Oct 2011 | - | -$2.91 M(-1.3%) |
| July 2011 | - | -$2.95 M(-10.1%) |
| Apr 2011 | -$3.28 M(+8.1%) | -$3.28 M(-2.7%) |
| Jan 2011 | - | -$3.38 M(+2.4%) |
| Oct 2010 | - | -$3.30 M(+1.1%) |
| July 2010 | - | -$3.26 M(+7.3%) |
| Apr 2010 | -$3.04 M(-1302.4%) | -$3.04 M(+25.6%) |
| Jan 2010 | - | -$2.42 M(+207.9%) |
| Oct 2009 | - | -$786.40 K(+29.6%) |
| July 2009 | - | -$607.00 K(-340.1%) |
| Apr 2009 | $252.80 K(-92.9%) | $252.80 K(-88.8%) |
| Jan 2009 | - | $2.26 M(-19.6%) |
| Oct 2008 | - | $2.81 M(-15.6%) |
| July 2008 | - | $3.32 M(-6.5%) |
| Apr 2008 | $3.55 M(+7.3%) | $3.55 M(+6.1%) |
| Jan 2008 | - | $3.35 M(+53.4%) |
| Oct 2007 | - | $2.18 M(-25.5%) |
| July 2007 | - | $2.93 M(-11.6%) |
| Apr 2007 | $3.31 M(+9.6%) | $3.31 M(+74.1%) |
| Jan 2007 | - | $1.90 M(-6.1%) |
| Oct 2006 | - | $2.03 M(-15.8%) |
| July 2006 | - | $2.41 M(-20.3%) |
| Apr 2006 | $3.02 M(-3664.5%) | $3.02 M(+2953.2%) |
| Jan 2006 | - | $99.00 K(-164.2%) |
| Oct 2005 | - | -$154.10 K(-21.7%) |
| July 2005 | - | -$196.90 K(+132.2%) |
| Apr 2005 | -$84.80 K(-165.0%) | -$84.80 K(-111.5%) |
| Jan 2005 | - | $734.90 K(-38.5%) |
| Oct 2004 | - | $1.20 M(-50.4%) |
| July 2004 | - | $2.41 M(+1746.8%) |
| Apr 2004 | $130.40 K(-5316.0%) | $130.40 K(+167.8%) |
| Jan 2004 | - | $48.70 K(-969.6%) |
| Oct 2003 | - | -$5600.00(+30.2%) |
| July 2003 | - | -$4300.00(+72.0%) |
| Apr 2003 | -$2500.00 | -$2500.00 |
FAQ
- What is PharmaCyte Biotech annual working capital?
- What is the all time high annual working capital for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual working capital year-on-year change?
- What is PharmaCyte Biotech quarterly working capital?
- What is the all time high quarterly working capital for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly working capital year-on-year change?
What is PharmaCyte Biotech annual working capital?
The current annual working capital of PMCB is $43.02 M
What is the all time high annual working capital for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual working capital is $84.79 M
What is PharmaCyte Biotech annual working capital year-on-year change?
Over the past year, PMCB annual working capital has changed by -$24.54 M (-36.33%)
What is PharmaCyte Biotech quarterly working capital?
The current quarterly working capital of PMCB is $25.40 M
What is the all time high quarterly working capital for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly working capital is $86.99 M
What is PharmaCyte Biotech quarterly working capital year-on-year change?
Over the past year, PMCB quarterly working capital has changed by -$43.11 M (-62.92%)